Home NDC 68703-030 CanTravel
Product NDC 68703-030
11-digit product format 687030030
Labeler code 68703
Product ID 68703-030_7f0a13d4-90a7-4d89-8fb1-f71cc9bed052
Type HUMAN OTC DRUG
Nonproprietary name Cocculusm, Kali phos, Mentha pip, Pulsatilla, Zingiber
Dosage form GRANULE
Route OCCLUSIVE DRESSING TECHNIQUE
Labeler Native Remedies, LLC
Marketing category UNAPPROVED HOMEOPATHIC
Marketing start 2012-08-01
Marketing end 0000-00-00
Substance ANAMIRTA COCCULUS SEED; POTASSIUM PHOSPHATE, DIBASIC; MENTHA PIPERITA; PULSATILLA VULGARIS; GINGER
Active strength 5 [hp_C]/40mg; [hp_C]/40mg; [hp_X]/40mg; [hp_C]/40mg; [hp_X]/40mg
NDC exclude flag E
Listing certified through 2018-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 44 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Code Status Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product I Inactivated by FDA d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 68703-030-20 I Inactivated by FDA d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product I Inactivated by FDA f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 68703-030-20 I Inactivated by FDA f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 68703-030-20 I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 68703-030-20 I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 68703-030-20 I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 68703-030-20 I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product I Inactivated by FDA 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 68703-030-20 I Inactivated by FDA 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product I Inactivated by FDA ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 68703-030-20 I Inactivated by FDA ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product I Inactivated by FDA 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 68703-030-20 I Inactivated by FDA 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product I Inactivated by FDA ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 68703-030-20 I Inactivated by FDA ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product I Inactivated by FDA 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 68703-030-20 I Inactivated by FDA 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product I Inactivated by FDA 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 68703-030-20 I Inactivated by FDA 557ba5c1ecfa…9c80585c8c6e…2024-05-28 21:12 UTC · source 2024-05-28 excluded product product I Inactivated by FDA 8af77b9d5b6f…d9bbb34c5368…2024-05-28 21:12 UTC · source 2024-05-28 excluded package package 68703-030-20 I Inactivated by FDA 8af77b9d5b6f…d9bbb34c5368…2024-05-15 03:39 UTC · source 2024-05-14 excluded product product I Inactivated by FDA 834df4deac94…adcc014656a3…2024-05-15 03:39 UTC · source 2024-05-14 excluded package package 68703-030-20 I Inactivated by FDA 834df4deac94…adcc014656a3…2024-03-11 06:39 UTC · source 2024-03-08 excluded product product I Inactivated by FDA 1332a3947898…d4bfe170f9cd…2024-03-11 06:39 UTC · source 2024-03-08 excluded package package 68703-030-20 I Inactivated by FDA 1332a3947898…d4bfe170f9cd…2022-08-30 03:57 UTC · source 2022-08-29 excluded product product I Inactivated by FDA fb8cb913e6d1…eb8c232b6be0…2022-08-30 03:57 UTC · source 2022-08-29 excluded package package 68703-030-20 I Inactivated by FDA fb8cb913e6d1…eb8c232b6be0…2022-04-09 23:13 UTC · source 2022-04-08 excluded product product I Inactivated by FDA 86f5da6cb304…a595104c45d7…2022-04-09 23:13 UTC · source 2022-04-08 excluded package package 68703-030-20 I Inactivated by FDA 86f5da6cb304…a595104c45d7…2022-04-04 05:40 UTC · source 2022-04-01 excluded product product I Inactivated by FDA bd6a592717d7…303034d00443…2022-04-04 05:40 UTC · source 2022-04-01 excluded package package 68703-030-20 I Inactivated by FDA bd6a592717d7…303034d00443…2021-12-27 23:28 UTC · source 2021-12-27 excluded product product I Inactivated by FDA 8dfbde2a14a4…c9ff85d89658…2021-12-27 23:28 UTC · source 2021-12-27 excluded package package 68703-030-20 I Inactivated by FDA 8dfbde2a14a4…c9ff85d89658…2020-12-18 03:04 UTC · source 2020-12-17 excluded product product I Inactivated by FDA e2bbac7714bc…27bdfed8d636…2020-12-18 03:04 UTC · source 2020-12-17 excluded package package 68703-030-20 I Inactivated by FDA e2bbac7714bc…27bdfed8d636…2020-06-10 20:45 UTC · source 2020-06-10 excluded product product I Inactivated by FDA 9bebd1f3094a…5416666fcb17…2020-06-10 20:45 UTC · source 2020-06-10 excluded package package 68703-030-20 I Inactivated by FDA 9bebd1f3094a…5416666fcb17…2019-12-08 06:16 UTC · source 2019-12-05 excluded product product E Excluded after deficient or non-compliant submission was not corrected 110d247fa046…a55b01930146…2019-12-08 06:16 UTC · source 2019-12-05 excluded package package 68703-030-20 E Excluded after deficient or non-compliant submission was not corrected 110d247fa046…a55b01930146…
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 68703-030-20 CanTravel 20000 mg in 1 BOTTLE, GLASS GRANULE 20000 1
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded ANAMIRTA COCCULUS SEED ACTIVE INGREDIENT 810258W28U CANTRAVEL (COCCULUSM, KALI PHOS, MENTHA PIP, PULSATILLA, ZINGIBER) GRANULE [NATIVE REMEDIES, LLC] 1 GINGER ACTIVE INGREDIENT C5529G5JPQ CANTRAVEL (COCCULUSM, KALI PHOS, MENTHA PIP, PULSATILLA, ZINGIBER) GRANULE [NATIVE REMEDIES, LLC] 1 MENTHA PIPERITA ACTIVE INGREDIENT 79M2M2UDA9 CANTRAVEL (COCCULUSM, KALI PHOS, MENTHA PIP, PULSATILLA, ZINGIBER) GRANULE [NATIVE REMEDIES, LLC] 1 POTASSIUM PHOSPHATE, DIBASIC ACTIVE INGREDIENT CI71S98N1Z CANTRAVEL (COCCULUSM, KALI PHOS, MENTHA PIP, PULSATILLA, ZINGIBER) GRANULE [NATIVE REMEDIES, LLC] 1 PULSATILLA VULGARIS ACTIVE INGREDIENT I76KB35JEV CANTRAVEL (COCCULUSM, KALI PHOS, MENTHA PIP, PULSATILLA, ZINGIBER) GRANULE [NATIVE REMEDIES, LLC] 1 ANAMIRTA COCCULUS SEED ACTIVE MOIETY 810258W28U CANTRAVEL (COCCULUSM, KALI PHOS, MENTHA PIP, PULSATILLA, ZINGIBER) GRANULE [NATIVE REMEDIES, LLC] 1 GINGER ACTIVE MOIETY C5529G5JPQ CANTRAVEL (COCCULUSM, KALI PHOS, MENTHA PIP, PULSATILLA, ZINGIBER) GRANULE [NATIVE REMEDIES, LLC] 1 MENTHA PIPERITA ACTIVE MOIETY 79M2M2UDA9 CANTRAVEL (COCCULUSM, KALI PHOS, MENTHA PIP, PULSATILLA, ZINGIBER) GRANULE [NATIVE REMEDIES, LLC] 1 PHOSPHATE ION ACTIVE MOIETY NK08V8K8HR CANTRAVEL (COCCULUSM, KALI PHOS, MENTHA PIP, PULSATILLA, ZINGIBER) GRANULE [NATIVE REMEDIES, LLC] 1 PULSATILLA VULGARIS ACTIVE MOIETY I76KB35JEV CANTRAVEL (COCCULUSM, KALI PHOS, MENTHA PIP, PULSATILLA, ZINGIBER) GRANULE [NATIVE REMEDIES, LLC] 1 CITRIC ACID MONOHYDRATE INACTIVE INGREDIENT 2968PHW8QP CANTRAVEL (COCCULUSM, KALI PHOS, MENTHA PIP, PULSATILLA, ZINGIBER) GRANULE [NATIVE REMEDIES, LLC] 1 POTASSIUM SORBATE INACTIVE INGREDIENT 1VPU26JZZ4 CANTRAVEL (COCCULUSM, KALI PHOS, MENTHA PIP, PULSATILLA, ZINGIBER) GRANULE [NATIVE REMEDIES, LLC] 1 STARCH, CORN INACTIVE INGREDIENT O8232NY3SJ CANTRAVEL (COCCULUSM, KALI PHOS, MENTHA PIP, PULSATILLA, ZINGIBER) GRANULE [NATIVE REMEDIES, LLC] 1 SUCROSE INACTIVE INGREDIENT C151H8M554 CANTRAVEL (COCCULUSM, KALI PHOS, MENTHA PIP, PULSATILLA, ZINGIBER) GRANULE [NATIVE REMEDIES, LLC] 1
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 68703-030 CANTRAVEL (COCCULUSM, KALI PHOS, MENTHA PIP, PULSATILLA, ZINGIBER) GRANULE [NATIVE REMEDIES, LLC] 1 Legacy NDC, 1 package rows 20120829_4d23455b-caf9-40ef-befb-eefb799d3639.zip
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Status 68703-030-20 68703003020 20000 mg in 1 BOTTLE, GLASS 20000 mg Historical